The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail info@hpra.ie


Rennie Dual Action Chewable Tablets Calcium carbonate 625mg Magnesium carbonate 73.5mg Alginic acid 150mg

625/73.5/150 milligram(s) Chewable tablet

Bayer LimitedPA1410/052/003

Main Information

Trade NameRennie Dual Action Chewable Tablets Calcium carbonate 625mg Magnesium carbonate 73.5mg Alginic acid 150mg
Active SubstancesAlginic acid
Calcium carbonate
Magnesium carbonate
Strength625/73.5/150 milligram(s)
Dosage FormChewable tablet
Licence HolderBayer Limited
Licence NumberPA1410/052/003

Group Information

ATC CodeA02AD Combinations and complexes of aluminium, calcium and magnesium compounds

Status

Authorised/WithdrawnAuthorised
Licence Issued06/02/2009
Legal statusProduct not subject to medical prescription
Supply StatusSupply through non-pharmacy outlets and pharmacies
Advertising StatusAdvertising to the general public
Conditions of Licence
Marketing StatusNot marketed

Documents

Summary of Product CharacteristicsPDF Version
Package LeafletPDF Version
Public Assessment ReportNo document available
« Back